Compare CURI & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CURI | STXS |
|---|---|---|
| Founded | N/A | 1990 |
| Country | United States | United States |
| Employees | 42 | N/A |
| Industry | Movies/Entertainment | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 154.7M | 164.1M |
| IPO Year | N/A | 2004 |
| Metric | CURI | STXS |
|---|---|---|
| Price | $2.72 | $1.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $5.83 | $4.00 |
| AVG Volume (30 Days) | 280.7K | ★ 1.2M |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | ★ 10.36% | N/A |
| EPS Growth | N/A | ★ 16.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $29,346,617.00 |
| Revenue This Year | $14.91 | $28.22 |
| Revenue Next Year | $12.91 | $30.47 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.30 | $1.24 |
| 52 Week High | $5.51 | $3.59 |
| Indicator | CURI | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 56.75 | 39.38 |
| Support Level | $2.32 | N/A |
| Resistance Level | $2.95 | $1.97 |
| Average True Range (ATR) | 0.11 | 0.10 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 98.57 | 30.77 |
CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. The firm's products and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, and Others. The majority of the revenue comes from the direct business and Content licensing. Geographically, the company generates the majority of its revenue from the United States.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.